Precision medicine for patients with advanced biliary tract cancers: Updated results from the prospective MOSCATO trial

被引：0
|
作者：
Verlingue, L. [1 ]
Malka, D. [2 ]
Allorant, A. [3 ]
Massard, C. [1 ]
Ferte, C. [4 ]
Lacroix, L. [5 ]
Rouleau, E. [6 ]
Auger, N. [7 ]
Delahousse, J. [8 ]
Sun, R. [9 ]
de Baere, T. [10 ]
Tselikas, L. [11 ]
Ba, B. [12 ]
Scoazec, J-Y. [13 ]
Michiels, S. [14 ]
Boige, V. [15 ]
Ducreux, M. [15 ]
Soria, J-C.
Hollebecque, A. [1 ]
机构：
[1] Gustave Roussy, Drug Dev Dept DITEP, Villejuif, France
[2] Inst Cancerol Gustave Roussy, Digest Oncol, Villejuif, France
[3] Gustave Roussy, Biostatist, Villejuif, France
[4] Gustave Roussy, Head & Neck, Villejuif, France
[5] Inst Gustave Roussy, BMO, Villejuif, France
[6] Gustave Roussy, Dept Biol & Pathol Med, Villejuif, France
[7] Gustave Roussy Canc Campus Grand Paris, Biol & Pathol Dept, Villejuif, France
[8] Inst Cancerol Gustave Roussy, Pharmacol, Villejuif, France
[9] Inst Gustave Roussy, Radiotherapy Dept, Radi INSERM U1030, Villejuif, France
[10] Inst Gustave Roussy, Radiol, Villejuif, France
[11] Gustave Roussy, Radiol, Villejuif, France
[12] Inst Cancerol Gustave Roussy, Radiol, Villejuif, France
[13] Gustave Roussy Inst, Pathol, Villejuif, France
[14] Gustave Roussy, Serv Biostat & Epidemiol, Villejuif, France
[15] Inst Gustave Roussy, Gastrointestinal Unit, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
726P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers
    Yoo, Changhoon
    Javle, Milind M.
    Mata, Helena Verdaguer
    de Braud, Filippo
    Trojan, Jorg
    Raoul, Jean-Luc
    Kim, Jin Won
    Ueno, Makoto
    Lee, Choong-kun
    Hijioka, Susumu
    Cubillo, Antonio
    Furuse, Junji
    Azad, Nilofer
    Sato, Masashi
    Vugmeyster, Yulia
    Machl, Andreas
    Bajars, Marcis
    Bridgewater, John
    Oh, Do-Youn
    Borad, Mitesh J.
    HEPATOLOGY, 2023, 78 (03) : 758 - 770
  • [42] Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial
    Aung, Kyaw L.
    Fischer, Sandra E.
    Denroche, Robert E.
    Jang, Gun-Ho
    Dodd, Anna
    Creighton, Sean
    Southwood, Bernadette
    Liang, Sheng-Ben
    Chadwick, Dianne
    Zhang, Amy
    O'Kane, Grainne M.
    Albaba, Hamzeh
    Moura, Shari
    Grant, Robert C.
    Miller, Jessica K.
    Mbabaali, Faridah
    Pasternack, Danielle
    Lungu, Ilinca M.
    Bartlett, John M. S.
    Ghai, Sangeet
    Lemire, Mathieu
    Holter, Spring
    Connor, Ashton A.
    Moffitt, Richard A.
    Yeh, Jen Jen
    Timms, Lee
    Krzyzanowski, Paul M.
    Dhani, Neesha
    Hedley, David
    Notta, Faiyaz
    Wilson, Julie M.
    Moore, Malcolm J.
    Gallinger, Steven
    Knox, Jennifer J.
    CLINICAL CANCER RESEARCH, 2018, 24 (06) : 1344 - 1354
  • [43] Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial
    Billon, Emilien
    Gravis, Gwenaelle
    Guille, Arnaud
    Carbuccia, Nadine
    Adelaide, Jose
    Garnier, Severine
    Finetti, Pascal
    Denicolai, Emilie
    Sfumato, Patrick
    Brunelle, Serge
    Thomassin-Piana, Jeanne
    Pignot, Geraldine
    Walz, Jochen
    Chabannon, Christian
    Pakradouni, Jihane
    Sabatier, Renaud
    Vicier, Cecile
    Popovici, Cornel
    Mamessier, Emilie
    Goncalves, Anthony
    Birnbaum, Daniel
    Chaffanet, Max
    Bertucci, Francois
    CANCERS, 2022, 14 (09)
  • [44] A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers
    Laura W. Goff
    Dana B. Cardin
    Jennifer G. Whisenant
    Liping Du
    Tatsuki Koyama
    Kimberly B. Dahlman
    Safia N. Salaria
    Ruth T. Young
    Kristen K. Ciombor
    Jill Gilbert
    Stephen James Smith
    Emily Chan
    Jordan Berlin
    Investigational New Drugs, 2017, 35 : 95 - 104
  • [45] A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers
    Goff, Laura W.
    Cardin, Dana B.
    Whisenant, Jennifer G.
    Du, Liping
    Koyama, Tatsuki
    Dahlman, Kimberly B.
    Salaria, Safia N.
    Young, Ruth T.
    Ciombor, Kristen K.
    Gilbert, Jill
    Smith, Stephen James
    Chan, Emily
    Berlin, Jordan
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (01) : 95 - 104
  • [46] A phase II trial of gemcitabine (G), cisplatin (C), and nab-paclitaxel (N) in advanced biliary tract cancers (aBTCs): Updated survival analysis.
    Shroff, Rachna T.
    Javle, Milind M.
    Xiao, Lianchun
    Kaseb, Ahmed Omar
    Varadhachary, Gauri R.
    Wolff, Robert A.
    Raghav, Kanwal Pratap Singh
    Iwasaki, Michiko
    Masci, Peter
    Ramanathan, Ramesh K.
    Ahn, Daniel H.
    Bekaii-Saab, Tanios S.
    Borad, Mitesh J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [47] Biomarker analysis of first-line camrelizumab plus apatinib in patients with advanced biliary tract cancers: Results from a phase II study.
    Rao, Jian-Hua
    Chen, Dong-Sheng
    Song, Yunjie
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16164 - E16164
  • [48] Multicentric prospective study assessing clinical benefit of targeted treatment for patients with biliary tract cancers
    Niger, M.
    Nichetti, F.
    Solda, C.
    Pressiani, T.
    Bagala, C.
    Masi, G.
    Pircher, C.
    De Grandis, M.
    Barsotti, G.
    Zanuso, V.
    Bensi, M.
    Genovesi, V.
    Pruneri, G.
    Ricagno, G.
    Rimassa, L.
    Salvatore, L.
    Vivaldi, C.
    Bergamo, F.
    Pietrantonio, F.
    de Braud, F.
    Lonardi, S.
    ANNALS OF ONCOLOGY, 2023, 34 : S7 - S8
  • [49] Use, response and outcomes of second-line chemotherapy in patients with advanced biliary tract cancers
    Mathers, Brittney
    Abadi, Shirin
    Davies, Janine M.
    McIntyre, Connor
    Ho, Cheryl
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, : 1381 - 1386
  • [50] Targeting HER2 mutation-positive advanced biliary tract cancers with neratinib: Final results from the phase 2 SUMMIT basket trial.
    Harding, James J.
    Piha-Paul, Sarina Anne
    Shah, Ronak H.
    Cleary, James M.
    Quinn, David I.
    Brana, Irene
    Moreno, Victor
    Borad, Mitesh J.
    Loi, Sherene
    Spanggaard, Iben
    Ford, James M.
    DiPrimeo, Daniel
    Berger, Michael F.
    Eli, Lisa DeFazio
    Meric-Bernstam, Funda
    Solit, David B.
    Abou-Alfa, Ghassan K.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345